Treatment of Osteoporosis with Bisphosphonates
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 27 (1) , 197-214
- https://doi.org/10.1016/s0889-857x(05)70194-0
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Pharmacokinetics of AlendronateClinical Pharmacokinetics, 1999
- IbandronateDrugs, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronateJournal of Bone and Mineral Research, 1995
- Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humansJournal of Clinical Endocrinology & Metabolism, 1993
- Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.Thorax, 1992
- Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)Drug Safety, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- SYMPTOMATIC HYPOCALCAEMIA AFTER TREATMENT WITH HIGH-DOSE AMINOHYDROXYPROPYLIDENE DIPHOSPHONATEThe Lancet, 1987
- Diphosphonates: History and mechanisms of actionMetabolic Bone Disease and Related Research, 1981